Drug Type Bispecific antibody |
Synonyms IL-1 trap and anti-HTRA1 bispecific |
Target |
Mechanism HTRA1 inhibitors(HtrA serine peptidase 1 inhibitors), IL1 agonists(Interleukin 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
dry age-related macular degeneration | Preclinical | US | 23 Apr 2023 |